Press release
British Portuguese Company, Bluestain Global, launches its own MPox virus detection product
The new rapid detection test for the mpox virus promises to be a game-changer in global health, delivering unmatched speed and accuracy at a critical moment.Bluestain Global [https://bluestainglobal.com/], a British Portuguese joint-venture, based in London, announced today at a press conference in Porto, Portugal, the launch of the Bluestain MPox virus detection kit.
The new rapid detection test for the mpox virus promises to be a game-changer in global health, delivering unmatched speed and accuracy at a critical moment. This launch follows the successful Bluestain cancer detection product the company introduced to the global market a few months ago.
A Visionary Response to a Global Crisis
The roots of this remarkable achievement trace back to March 2020, when the COVID-19 pandemic brought the world to a standstill. Amidst this unprecedented crisis, Professor Fernando Ferreira and Professor Paula Melo, both co-founders of Bluestain Global, and globally recognized scientists, invented at that time a Covid detection test kit. The test kit was successfully used by many authorities in Portugal and was playing a critical role in Portugal's pandemic response.
Enter BlueStain Global: A New Era of Diagnostics
Building on the legacy of success, Prof. Ferreira and Prof. Melo launched BlueStain Global, a joint venture with British IKAR Holdings, a multi-tiered entrepreneurial group, based in London.
The new venture is focusing on developing rapid diagnostic tests for emerging health threats.
Their new innovation, the "BlueStain Mpox Test," is a testament to their continued dedication to global health.
Image: https://www.abnewswire.com/uploads/0a89378b1bb0314fc9c29b342daa3057.jpeg
The "BlueStain Mpox Test": A Game-Changer for Public Health
The "BlueStain Mpox Test" represents a quantum leap in virus detection. Engineered with cutting-edge molecular techniques, this test offers unparalleled sensitivity and specificity. It is designed to deliver results within 15 to 30 minutes, making it an indispensable tool for healthcare providers in the early detection and containment of mpox outbreaks.
What sets the "BlueStain Mpox Test" apart is its user-friendly design. The test requires minimal training to administer, making it ideal for deployment in both clinical settings and in the field. This rapid turnaround time is critical in curbing the spread of the virus, particularly in high-risk populations or regions where mpox has the potential to cause widespread harm.
A Powerful Tool Against the Mpox Pandemic
The mpox virus poses a significant threat, especially in regions with limited healthcare infrastructure. Early detection is the linchpin in preventing large-scale outbreaks and ensuring timely treatment. The "BlueStain Mpox Test" is poised to be a crucial asset in this fight.
Prof. Ferreira, Chairman of Bluestain Global stated: "By delivering fast and accurate results, the "BlueStain Mpox Test" empowers health authorities to act swiftly-isolating infected individuals, initiating contact tracing, and implementing other containment strategies without delay. This rapid response capability is vital in breaking the chain of transmission and mitigating the virus's impact on communities.
Furthermore, the accessibility of the "BlueStain Mpox Test" makes it a powerful tool in resource-limited settings, where advanced laboratory infrastructure is often lacking. By bridging the gap between high-income and low-income regions, this test ensures that even the most vulnerable populations can benefit from early detection and effective treatment".
Prof. Melo, board member of Bluestain Global added: "As the "BlueStain Mpox Test" gears up for commercialization in the coming months, it stands to revolutionize global efforts to combat the mpox virus. This innovation is more than just a diagnostic tool-it is a beacon of hope in the fight against an emerging pandemic, offering the speed and accuracy needed to protect public health on a global scale".
Conclusion: A Legacy of Innovation and Impact
From their decisive action during the COVID-19 pandemic to their latest innovation with the "BlueStain Mpox Test," Fernando Ferreira and Paula Melo have consistently proven themselves as leaders in the field of diagnostics. The establishing of BlueStain Global as a frontrunner in virus detection-speaks to their vision, dedication, and ability to anticipate and respond to global health challenges.
"As BlueStain Global prepares to bring the "BlueStain Mpox Test" to the market, the world stands on the brink of a new era in public health. This test is not just a product; it is a vital tool in the ongoing battle against viral threats, positioning BlueStain Global at the forefront of efforts to safeguard global health and prevent future pandemics. The launch of the "BlueStain Mpox Test" is a powerful statement of the company's unwavering commitment to innovation and its mission to protect lives worldwide! As we believe that our new product will help so many people, we are constantly supporting the R&D process by financing the company through UPT token, as the overall strategy of the Unify Platform token is to support outstanding products for the betterment of the world and its humans", said Sertan Aycicek, Group CEO of IKAR Holding, and member of the board of Bluestain Global.
About Bluestain Global
BlueStain Global Ltd is a company established in London, UK between CESPU Diagnostico (Portugal) and IKAR Holdings (United Kingdom).
The company is focusing on the healthcare sector and in particular providing rapid diagnostic tests for emerging health threats.
The combined experience and knowledge of globally recognized scientists with the entrepreneurial mindset and execution of the partners makes the company a unique setup within the health industry.
Media Contact
Company Name: Bluestain Global
Contact Person: Media relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=british-portuguese-company-bluestain-global-launches-its-own-mpox-virus-detection-product]
Address:Beaufort Court, Admirals Way
City: London, E14 9XL
Country: United Kingdom
Website: http://www.bluestainglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release British Portuguese Company, Bluestain Global, launches its own MPox virus detection product here
News-ID: 3627208 • Views: …
More Releases from ABNewswire

Global Sound Reinforcement Market Set to Grow at 4.28% CAGR, Reaching USD 38.58 …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
The global sound reinforcement market [https://www.arizton.com/market-reports/sound-reinforcement-market-size-growth] is projected to expand from USD 30 billion in 2024 to USD 38.58 billion by 2030, growing at a steady 4.28% CAGR, according to Arizton. This growth is being driven by rising demand for high-quality audio solutions across live events and entertainment venues. Advances in audio technology have significantly enhanced…

Gelt Raises $13M Series A to Expand AI-Powered Tax Solutions for Real Estate Inv …
Miami, FL - September 30, 2025 - Gelt [https://www.joingelt.com/], the first AI-native tax firm for investors and the Top 1% in the U.S., today announced it has raised $13 million in Series A [https://www.businesswire.com/news/home/20250930325477/en/Gelt-the-First-AI-Native-Tax-Firm-Raises-%2413M-in-Series-A-Funding-to-Transform-Tax-Strategy-Into-Year-Round-Wealth-Optimization], bringing its total funding to $21.2 million. Global investors, Zvi Limon of the Rimon Group, Vintage Investment Partners, and TLV Partners led the funding. As part of the launch, Yoram Tietz, former Managing Partner at EY…

Applications of 5-50mm security camera lens
The application scenarios of 5-50 mm surveillance lenses are primarily categorized according to the variations in field of view resulting from changes in focal length. The specific applications are as follows:
1. Wide-angle range (5-12 mm)
Panoramic monitoring for confined spaces A focal length of 5-8 mm (with a field of view of 60 degrees -90 degrees ) is suitable for enclosed small areas within 5 times 5 meters, such as elevator…

Daniel Smart Manufacturing Empowers Riders with their New Custom Builder Feature …
A leather jacket [https://danielsmartmfg.com/collections/mens-leather-motorcycle-jackets] for a rider is an essential part of their ride, and it makes them feel incomplete without it whenever they hit the road. If you are a biker, you must know what it means. Now imagine you can design your leather jacket your way, which may further enhance your experience on the road. Well, Daniel Smart, a renowned brand in the leather jacket industry, is now…
More Releases for BlueStain
Rising Prevalence Of Viral Infections Propels Growth Of Viral Diagnostic Test Ki …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Viral Diagnostic Test Kits Market Size By 2025?
Recently, there has been a significant growth in the market size of viral diagnostic test kits. This market, valued at $16.26 billion in 2024, is expected to expand to $17.62 billion in 2025, showcasing a compound annual…
Global Viral Diagnostic Test Kits Market Analysis 2025-2030: Growth Drivers, Cha …
The Viral Diagnostic Test Kits Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Viral Diagnostic Test Kits Market Size Expected to Be by 2034?
The viral diagnostic test kits market has experienced robust growth in recent years. It is projected to rise…
Viral Diagnostic Test Kits Market Outlook 2025-2034: Key Trends, Growth Drivers, …
How Are the key drivers contributing to the expansion of the viral diagnostic test kits market?
The rising prevalence of viral infections is expected to propel the growth of the viral diagnostic test kits market. The incidence of viral infections is increasing due to factors such as global travel, urbanization, and climate change, which are influencing the spread of viral diseases. Additionally, evolving viral strains can cause new outbreaks, further contributing…
Rising Prevalence Of Viral Infections Propels Growth Of Viral Diagnostic Test Ki …
What Are the Projected Growth and Market Size Trends for the Viral Diagnostic Test Kits Market?
The market size for viral diagnostic test kits has seen robust growth in the recent past. The market, valued at $16.26 billion in 2024, is projected to expand to $17.62 billion in 2025, with an impressive compound annual growth rate (CAGR) of 8.4%. The market's significant growth during the historical period is a result of…
"Global Partnership Announced between British IKAR Arabia Investment Group and P …
British IKAR Arabia Investment Group Limited, and Portuguese CESPU Diagnóstico, S.A., have announced today the establishment of a global partnership in the healthcare industry.
Both parties agreed to establish "BlueStain Global Limited", headquartered in London.
CESPU Diagnóstico, is part of Portuguese CESPU Group, which is a Higher Education Institution that has been training highly qualified health professionals for over 40 years.
IKAR Arabia Investment Group is one of the vertical operating groups, belonging…